FRED ALGER MANAGEMENT, LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 3520 NEW YORK, NY

Position in LNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,334,865

+$8,720,095 QoQ

Shares Held

136,254

+590.7% QoQ

Ownership

0.209%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FRED ALGER MANAGEMENT, LLC holds $17,745,861 across 6 Drug Manufacturers - Specialty & Generic names. LNTH ranks #1 (58.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc. This page	136,254	$10,334,865
2	UTHR	UNITED THERAPEUTICS Corp	4,522	$2,681,455
3	TEVA	Teva Pharmaceutical Industries Ltd	81,865	$2,465,773
4	BCRX	Biocryst Pharmaceuticals Inc	123,961	$1,180,108
5	ZTS	Zoetis Inc.	7,305	$863,523
6	NBIX	Neurocrine Biosciences Inc	1,671	$220,137

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,334,865	136,254	+590.7%	Shares	Sole	2026-05-15
2025-06-30	$1,614,770	19,726	—	Shares	Sole	2025-08-14
No filing history on record for this holder in this stock.